Track Pfizer Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Pfizer Inc. PFE.DE · Stock Open Pfizer Inc. in new tab

22.65 EUR
P/E
19.53
EPS
1.14
Yield
6.78%
Safety Score
16
P/B
1.64
ROE
8.31
Beta
0.30
Loading chart...
Key Metrics
Earnings dateJuly 29, 2026
P/E19.53
EPS1.14
Book Value13.59
Price to Book1.64
Debt/Equity71.60
% Insiders0.096%
Growth
Revenue Growth0.05%
Earnings Growth-0.10%
Dividend
Dividend Yield6.78%
Annual dividends1.72 EUR
Ex-Div. DateMay 8, 2026
Payout130.54%
5y avg Yield4.49%

DCF Valuation

Tweak assumptions to recompute fair value for Pfizer Inc. (PFE.DE)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Pfizer Inc. Logo Pfizer Inc. Analysis (PFE.DE)

United States Health Care Official Website Stock

Is Pfizer Inc. a good investment? Pfizer Inc. (PFE.DE) is currently trading at 22.65 EUR.

In terms of valuation, the stock trades at a P/E ratio of 19.53. This valuation is generally in line with the broader market.

Earnings Schedule: Pfizer Inc. is expected to release its next earnings report on July 29, 2026.

For income investors, Pfizer Inc. pays a dividend yield of 6.78%. With a payout ratio of 131%, the dividend appears to be under pressure.

Investor FAQ

Does Pfizer Inc. pay a dividend?

Yes, it pays an annual dividend of 1.72 EUR (6.78% yield).

What asset class is Pfizer Inc.?

Pfizer Inc. is classified as a Stock. You can compare it against 13 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be July 29, 2026. The company currently has a trailing EPS of 1.14.

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Exchange Ticker
SGO (Chile) PFE.SN
DUS (Germany) PFE.DU
NYQ (United States) PFE
BER (Germany) PFE.BE
HAN (Germany) PFE.HA
HAM (Germany) PFE.HM
MEX (Mexico) PFE.MX
STU (Germany) PFE.SG
STO (Sweden) PFE.ST
VIE (Austria) PFE.VI
SAO (Brazil) PFIZ34.SA
GER (Germany) PFE.DE
FRA (Germany) PFE.F
Trades
Dividend Yield
6.78%
5y avg 4.49%
Annual Dividends
1.72EUR
Next Ex. Div Date
May 8, 2026
Payout Ratio
130.54%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
0.38 EUR
March 1, 2027 (estimated) 0.3815
2026
1.51 EUR
Dec. 1, 2026 (estimated) 0.3815
Sept. 3, 2026 (estimated) 0.3815
June 12, 2026 0.3721
March 6, 2026 0.3721
2025
1.49 EUR
Dec. 1, 2025 0.3721
Sept. 2, 2025 0.3721
June 13, 2025 0.3721
March 7, 2025 0.3721
2024
1.45 EUR
Dec. 2, 2024 0.3634
Sept. 3, 2024 0.3634
June 14, 2024 0.3634
March 1, 2024 0.3634
2023
1.42 EUR
Dec. 4, 2023 0.3548
Sept. 5, 2023 0.3548
June 9, 2023 0.3548
March 3, 2023 0.3548
2022
1.38 EUR
Dec. 5, 2022 0.3461
Sept. 6, 2022 0.3461
June 10, 2022 0.3461
March 4, 2022 0.3461
2021
1.35 EUR
Dec. 6, 2021 0.3375
Sept. 7, 2021 0.3375
June 4, 2021 0.3375
March 5, 2021 0.3375
2020
1.32 EUR
Dec. 1, 2020 0.3288
Sept. 1, 2020 0.3288
June 5, 2020 0.3288
March 6, 2020 0.3288
2019
1.58 EUR
Dec. 2, 2019 0.3115
Sept. 3, 2019 0.3115
July 31, 2019 0.3325
June 7, 2019 0.3115
March 1, 2019 0.3115
2018
1.49 EUR
Dec. 3, 2018 0.2942
Sept. 4, 2018 0.2942
June 1, 2018 0.2942
March 1, 2018 0.2942
Jan. 31, 2018 0.3140
2017
1.45 EUR
Dec. 1, 2017 0.3200
Sept. 1, 2017 0.2769
June 1, 2017 0.2769
March 1, 2017 0.2769
Jan. 31, 2017 0.2955
2016
1.04 EUR
Dec. 1, 2016 0.2596
Sept. 1, 2016 0.2596
June 1, 2016 0.2596
March 2, 2016 0.2596
2015
0.97 EUR
Dec. 1, 2015 0.2423
Sept. 2, 2015 0.2423
June 2, 2015 0.2423
March 3, 2015 0.2423
2014
0.90 EUR
Dec. 2, 2014 0.2250
Sept. 3, 2014 0.2250
June 3, 2014 0.2250
March 4, 2014 0.2250
2013
0.83 EUR
Dec. 3, 2013 0.2077
Sept. 4, 2013 0.2077
June 4, 2013 0.2077
March 5, 2013 0.2077
2012
1.17 EUR
Dec. 4, 2012 0.1904
Aug. 1, 2012 0.1904
July 31, 2012 0.2032
June 5, 2012 0.1904
Feb. 1, 2012 0.1904
Jan. 31, 2012 0.2032
2011
0.69 EUR
Dec. 6, 2011 0.1731
Sept. 6, 2011 0.1731
June 7, 2011 0.1731
March 1, 2011 0.1731
2010
0.62 EUR
Dec. 1, 2010 0.1558
Sept. 1, 2010 0.1558
June 1, 2010 0.1558
March 2, 2010 0.1558
2009
2.05 EUR
Dec. 1, 2009 0.1384
Sept. 2, 2009 0.1384
June 2, 2009 0.1384
April 9, 2009 0.3461
April 8, 2009 0.3694
March 3, 2009 0.2769
Jan. 13, 2009 0.3115
Jan. 12, 2009 0.3325
2008
3.04 EUR
Dec. 2, 2008 0.2769
Oct. 10, 2008 0.3115
Oct. 9, 2008 0.3325
Sept. 3, 2008 0.2769
July 11, 2008 0.3115
July 10, 2008 0.3325
June 3, 2008 0.2769
April 11, 2008 0.3115
April 10, 2008 0.3325
March 4, 2008 0.2769
2007
0.28 EUR
Dec. 4, 2007 0.2812
Upcoming Dividends
Name Payment Date Status Amount
Pfizer Inc. Jun 12, 2026 0.372079 EUR
Pfizer Inc. Mar 06, 2026 0.372079 EUR
Pfizer Inc. Dec 01, 2025 0.372079 EUR
Pfizer Inc. Sep 02, 2025 0.372079 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion